Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470502) titled 'MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease' on March 10.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Meyer Children's Hospital IRCCS
Condition:
IBD (Inflammatory Bowel Disease)
Intervention:
Diagnostic Test: Infliximab level analysis in biological samples
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: February 13, 2025
Target Sample Size: 15
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/...